Lab Co of America

$267.32 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Lab Co of America

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Stock Analysis

last close $260.43
1-mo return -5.1%
3-mo return 8.5%
avg daily vol. 750.72T
52-week high 280.69
52-week low 155.65
market cap. $25.3B
forward pe 14.8
annual div. -
roe 31%
ltg forecast -11%
dividend yield -
annual rev. $15.3B
inst own. 94.4%
baraka

Subscribe now for daily local and international financial news

Subscribe